Navigation Links
LUNGevity Hosts Post-ASCO Lung Cancer Recap
Date:6/18/2011

WASHINGTON, June 18, 2011 /PRNewswire-USNewswire/ -- LUNGevity Foundation and GRACE announce a free webinar program to provide the highlights in lung cancer research from the American Society for Clinical Oncology (ASCO) Annual Meeting held June 3-6, 2011 in Chicago.  ASCO, the largest cancer conference of the year, is where the majority of the landmark clinical research in cancer care are presented.  On the webinar participants will learn the results of the key research and also have it placed into context with valuable commentary by two expert lung cancer oncologists. For more information and to register, visit http://events.lungevity.org/site/PageServer?pagename=podcasts_webinars.

About LUNGevity Foundation

The mission of LUNGevity Foundation is to have a meaningful and immediate impact on improving lung cancer survival rates, ensure a higher quality of life for lung cancer patients, and provide a community for those impacted by lung cancer.

In order to accomplish its mission, LUNGevity funds the most promising research into the early detection and successful treatment of lung cancer as identified by its board of leading scientists. LUNGevity also supports the largest national grassroots lung cancer network.

LUNGevity seeks to inspire the nation to commit to ending lung cancer.

For more information, please visit www.lungevity.org.

About Lung Cancer

  • Lung cancer impacts 1 in 14 Americans and is the number one cancer killer.
  • About 65 percent of Americans diagnosed with lung cancer either never smoked a cigarette in their lives or had quit smoking.
  • Less than 15 percent of people diagnosed with lung cancer survive 5 years post-diagnosis because of limited early detection opportunities.
  • There is no widely available, effective early diagnostic test available today.

About GRACE

The mission of the Global Resource for Advancing Cancer Education (GRACE) is to provide expert-mediated information on current and emerging cancer management options in order to empower patients, caregivers, and health professionals to become direct partners in cancer care. GRACE (www.cancerGRACE.org) was founded by Dr. Howard (Jack) West, a medical oncologist based in Seattle, to provide high quality, expert-mediated cancer information for the general public, specifically for patients, their families, and other caregivers, that is not available through other sources.  Since its inception, its faculty, breadth and depth of content, and international audience have grown rapidly.


'/>"/>
SOURCE LUNGevity Foundation
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. KGI Hosts Fourth Annual Conference for Women in Life Science Industry
2. J. Craig Venter Institute Hosts Genomics Education Program for DC Metro Area Teachers
3. Stevens hosts 2010 metro area NEMS/MEMS Workshop
4. Yongye International Hosts Official NASDAQ Visit to Inner Mongolia
5. Parasite plants rob genes from their hosts
6. GenomeQuest Hosts IP Workshop at Annual PIUG Conference in Baltimore
7. Toxikon Corporation Hosts Extractables and Leachables Spring Seminar
8. Chinese Biopharaceutical Association Hosts 2010 Chinese New Year Gala in Washington, DC
9. The American Society for Laser Medicine and Surgery Hosts Its 30th Annual Conference in Phoenix on April 14-18, 2010
10. Abbott Hosts Conference Call for Third-Quarter Earnings
11. CBI Hosts Life Sciences Summit on International Trade Compliance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... 27, 2016 , ... Newly created 4Sight Medical Solutions ... the healthcare market. The company's primary focus is on new product introductions, to ... that are necessary to help companies efficiently bring their products to market. , ...
(Date:6/24/2016)... Epic Sciences unveiled a liquid biopsy ... PARP inhibitors by targeting homologous recombination deficiency (HRD) ... test has already been incorporated into numerous clinical ... Over 230 clinical trials are investigating ... PARP, ATM, ATR, DNA-PK and WEE-1. Drugs targeting ...
(Date:6/23/2016)... , June 23, 2016   Boston ... of novel compounds designed to target cancer stemness ... has been granted Orphan Drug Designation from the ... treatment of gastric cancer, including gastroesophageal junction (GEJ) ... inhibitor designed to inhibit cancer stemness pathways by ...
(Date:6/23/2016)... , June 23, 2016  The Prostate Cancer Foundation (PCF) is ... treatments and faster cures for prostate cancer. Members of the Class of 2016 ... countries. Read More About the Class of 2016 PCF ... ... ...
Breaking Biology Technology:
(Date:3/31/2016)... BOCA RATON, Florida , March 31, 2016 /PRNewswire/ ... LEGX ) ("LegacyXChange" or the "Company") ... presentation for potential users of its soon to be ... The video ( https://www.youtube.com/channel/UCyTLBzmZogV1y2D6bDkBX5g ) will also ... by the use of DNA technology to an industry ...
(Date:3/29/2016)... 29, 2016 LegacyXChange, Inc. (OTC: ... and SelectaDNA/CSI Protect are pleased to announce our successful ... a variety of writing instruments, ensuring athletes signatures against ... collectibles from athletes on LegacyXChange will be assured of ... DNA. Bill Bollander , CEO states, ...
(Date:3/22/2016)... March 22, 2016 ... Sensors Market for Consumer Industry by Type (Image, ... Application (Communication & IT, Entertainment, Home Appliances, ... Forecast to 2022", published by MarketsandMarkets, the ... to reach USD 26.76 Billion by 2022, ...
Breaking Biology News(10 mins):